⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of NaoBios and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
NaoBios
↗Saint-Herblain (near Nantes), France
NaoBios is a specialized Contract Development and Manufacturing Organization (CDMO) based in France, focusing on the bioprocess development and GMP manufacturing of virus-based products. The company provides end-to-end services, including process and analytical development, preclinical and clinical batch production, and quality control testing for viral vaccines, viral vectors, oncolytic viruses, and human viral challenge agents.
As a subsidiary of the Clean Biologics group, NaoBios operates multipurpose BSL2 and BSL3 laboratories and manufacturing suites. They are recognized for their expertise in handling a wide range of viruses and cell substrates, supporting clients from early-stage development through to clinical phases, with a strong emphasis on scalable, industrial-grade processes.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO Service Provider)
Modalities:Viral vectors, Viral vaccines, Oncolytic viruses, Exosomes
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Clean Biologics
Acquired By:Clean Biologics (2019-01-01)
Key Partnerships:SGS (Manufacturing of RSV challenge agent), European Vaccine Initiative (Inno4Vac consortium), Nuvonis (Cell bank collaboration), Sumagen (HIV vaccine development)
COMPETITION
Position:Niche Player
Competitors:Clean Cells (Sister company, often collaborates), Other European viral vector CDMOs
LEADERSHIP
Key Executives:
Eric Le Forestier - General Manager
LINKS
Website:naobios.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NaoBios. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.